2
|
Di Gioia S, Rejman J, Carrabino S, De Fino I, Rudolph C, Doherty A, Hyndman L, Di Cicco M, Copreni E, Bragonzi A, Colombo C, Boyd AC, Conese M. Role of Biophysical Parameters on ex Vivo and in Vivo Gene Transfer to the Airway Epithelium by Polyethylenimine/Albumin Complexes. Biomacromolecules 2008; 9:859-66. [DOI: 10.1021/bm701190p] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Sante Di Gioia
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Joanna Rejman
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Salvatore Carrabino
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Ida De Fino
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Carsten Rudolph
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Ann Doherty
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Laura Hyndman
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Maurizio Di Cicco
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Elena Copreni
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Alessandra Bragonzi
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Carla Colombo
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - A. Christopher Boyd
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| | - Massimo Conese
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy, Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany, Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, Berlin, Germany, Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh, U.K., Dipartimento di Otorinolaringoiatra, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli
| |
Collapse
|